Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    May 2022
  1. TASOUDIS P, Kyriakoulis I, Sagris D, Diener HC, et al
    Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
    Thromb Haemost. 2022 May 16. doi: 10.1055/a-1853-2952.
    PubMed     Abstract available


    April 2022
  2. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    PubMed     Abstract available


    March 2022
  3. DEL BIANCO-RONDEAU M, Robert-Halabi M, Bloom S, Rabasa-Lhoret R, et al
    Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities.
    Thromb Haemost. 2022 Mar 4. doi: 10.1055/s-0042-1743469.
    PubMed     Abstract available


  4. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed     Abstract available


    February 2022
  5. LOPEZ-GALVEZ R, Rivera-Caravaca JM
    Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4206.
    PubMed     Abstract available


  6. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    PubMed     Abstract available


    January 2022
  7. CLELAND JGF
    Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Thromb Haemost. 2022 Jan 20. doi: 10.1055/s-0041-1740639.
    PubMed    


  8. CANTONI S, Colombo C, Soriano F, Oreglia JA, et al
    RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.
    Thromb Haemost. 2022 Jan 17. doi: 10.1055/a-1742-0361.
    PubMed     Abstract available


  9. GOROG DA, Massberg S
    NETs in the infarct-related coronary artery - a marker or mediator of adverse outcome?
    Thromb Haemost. 2022 Jan 10. doi: 10.1055/a-1733-9217.
    PubMed     Abstract available


  10. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    PubMed     Abstract available


    November 2021
  11. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    PubMed     Abstract available


    October 2021
  12. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
    Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
    PubMed     Abstract available


  13. MCCUTCHEON K, Manga P
    Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
    PubMed    


  14. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    PubMed     Abstract available


  15. JEONG YH, Oh JH, Yoon HJ, Park Y, et al
    Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial.
    Thromb Haemost. 2021;121:1376-1386.
    PubMed     Abstract available


    September 2021
  16. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available


    July 2021
  17. VERA A, Rivero F, Salamanca J, Alvarado-Casas T, et al
    Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
    Thromb Haemost. 2021;121:976-978.
    PubMed     Abstract available


    June 2021
  18. PEDERSEN OB, Grove EL, Kristensen SD, Nissen PH, et al
    MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease.
    Thromb Haemost. 2021 Jun 6. doi: 10.1055/s-0041-1730375.
    PubMed     Abstract available


    May 2021
  19. HALLY KE, Parker OM, Brunton-O'Sullivan MM, Harding SA, et al
    Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction.
    Thromb Haemost. 2021 May 13. doi: 10.1055/s-0041-1728763.
    PubMed     Abstract available


    March 2021
  20. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
    Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
    PubMed     Abstract available


    February 2021
  21. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    PubMed     Abstract available


  22. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    PubMed     Abstract available


    January 2021
  23. GUEDENEY P, Collet JP
    Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
    Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
    PubMed     Abstract available


  24. HENNING C, Branopolski A, Follert P, Lewandowska O, et al
    Endothelial beta1 Integrin-Mediated Adaptation to Myocardial Ischemia.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1721505.
    PubMed     Abstract available


  25. STOJKOVIC S, Wadowski PP, Haider P, Weikert C, et al
    Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722226.
    PubMed     Abstract available


  26. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    PubMed     Abstract available


    December 2020
  27. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
    PubMed    


  28. ARROYO AB, Aguila S, Fernandez-Perez MP, DE Los Reyes-Garcia AM, et al
    miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?
    Thromb Haemost. 2020 Dec 22. doi: 10.1055/a-1342-3648.
    PubMed     Abstract available


  29. CAO YX, Zhang HW, Jin JL, Liu HH, et al
    Lipoprotein(a) and cardiovascular outcomes in patients with previous myocardial infarction: a prospective cohort study.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2109.
    PubMed     Abstract available


  30. KAZEM N, Hofer F, Koller L, Hammer A, et al
    The age-specific impact of cellular immunity on long-term outcome after acute coronary syndrome.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2055.
    PubMed     Abstract available


  31. FABER J, Hvas AM, Kristensen SD, Grove EL, et al
    Immature Platelets and Risk of Cardiovascular Events among Patients with Ischemic Heart Disease: A Systematic Review.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721386.
    PubMed     Abstract available


  32. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available


    November 2020
  33. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    


  34. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available


  35. KIM HK, Tantry US, Smith SC Jr, Jeong MH, et al
    The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718729.
    PubMed     Abstract available


    October 2020
  36. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available


  37. GENCER S, Lacy M, Atzler D, van der Vorst EPC, et al
    Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
    Thromb Haemost. 2020 Oct 29. doi: 10.1055/s-0040-1718735.
    PubMed     Abstract available


  38. GUILLET B, Cayla G, Lebreton A, Trillot N, et al
    Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718410.
    PubMed     Abstract available


    March 2020
  39. PANDEY AK, Xu K, Zhang L, Gupta S, et al
    Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Thromb Haemost. 2020;120:484-494.
    PubMed     Abstract available


  40. RAMOTOWSKI B, Gurbel PA, Tantry U, Bracha JS, et al
    Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.
    Thromb Haemost. 2020;120:449-456.
    PubMed     Abstract available


    February 2020
  41. KNOPP T, Karbach S, Wenzel P
    Myeloid Cells to the Rescue: Improving Thrombus Resolution.
    Thromb Haemost. 2020;120:197-198.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: